Literature DB >> 7994029

Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist.

M J Aman1, U Keller, G Derigs, M Mohamadzadeh, C Huber, C Peschel.   

Abstract

We investigated the effects of interferon-alpha (IFN-alpha) on the expression of cytokines by human bone marrow stromal cells. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), and interleukin-1 beta (IL-1 beta) in stromal cell layers was induced by incubation with IL-1 alpha, tumor necrosis factor (TNF), or lipopolysaccharide (LPS). Addition of IFN-alpha to such stimulated cultures resulted in a strong downregulation of mRNA expression of GM-CSF and IL-1 beta. Similarly, the protein levels of GM-CSF and IL-1 beta were significantly reduced by IFN-alpha, whereas G-CSF production was only moderately inhibited. In contrast, IFN-alpha markedly stimulated the production of IL-1 receptor antagonist (IL-1RA) by stromal cells. The inhibition of cytokine expression resulted in a reduced hematopoietic activity of stromal cells, indicated by a reduced proliferation of the factor dependent cell line MO7e on IFN-alpha-treated stromal cells. In the presence of cycloheximide (CHX), IFN-alpha failed to inhibit IL-1 mRNA expression, whereas the regulation of GM-CSF and IL-1RA by IFN-alpha was not affected. Our results indicate that the myelosuppressive effects of IFN-alpha, as observed in therapeutic applications or associated with viral infections, are, in part, indirectly mediated by inhibition of the paracrine production of hematopoietic growth factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994029

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice.

Authors:  Liguo Niu; Simona Strahotin; Becker Hewes; Benyue Zhang; Yuanyuan Zhang; David Archer; Trent Spencer; Dirck Dillehay; Byoung Kwon; Lieping Chen; Anthony T Vella; Robert S Mittler
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

3.  T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.

Authors:  A Arizcorreta; M Márquez; C Fernández-Gutiérrez; E Pérez Guzmán; F Brun; M Rodríguez-Iglesias; J A Girón-González
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.

Authors:  Francine Bouchonnet; Neio Boechat; Marcel Bonay; Allan J Hance
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 5.  Novel and emerging therapies for the treatment of polycythemia vera.

Authors:  Srdan Verstovsek; Rami S Komrokji
Journal:  Expert Rev Hematol       Date:  2014-10-29       Impact factor: 2.929

Review 6.  Biotherapy of chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; F Schneller; C Huber
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

7.  Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens.

Authors:  H Müller-Alouf; J E Alouf; D Gerlach; J H Ozegowski; C Fitting; J M Cavaillon
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

8.  Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD.

Authors:  Lishu Zhang; Yan-Fang Guo; Yao-Zhong Liu; Yong-Jun Liu; Dong-Hai Xiong; Xiao-Gang Liu; Liang Wang; Tie-Lin Yang; Shu-Feng Lei; Yan Guo; Han Yan; Yu-Fang Pei; Feng Zhang; Christopher J Papasian; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

9.  Altered thymic function during interferon therapy in HCV-infected patients.

Authors:  Stephanie Beq; Sandra Rozlan; Sandy Pelletier; Bernard Willems; Julie Bruneau; Jean-Daniel Lelievre; Yves Levy; Naglaa H Shoukry; Rémi Cheynier
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

10.  Bone metabolism during interferon-alpha treatment of essential thrombocythemia.

Authors:  Rajko Kusec; Vesna Kusec; Bettina Gisslinger; Wolfgang Woloszczuk; Heinz Gisslinger
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.